metaraminol has been researched along with Syndrome in 2 studies
Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.
Syndrome: A characteristic symptom complex.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sicuteri, F | 1 |
Anselmi, B | 1 |
Del Bianco, PL | 1 |
Steiner, JA | 1 |
Low, PA | 1 |
Huang, CY | 1 |
West, M | 1 |
Uther, JB | 1 |
Allsop, JL | 1 |
Chalmers, JP | 1 |
2 other studies available for metaraminol and Syndrome
Article | Year |
---|---|
5-hydroxytryptamine supersensitivity as a new theory of headache and central pain: a clinical pharmacological approach with p-chlorophenylalanine.
Topics: Brain Chemistry; Drug Hypersensitivity; Fenclonine; Headache; Humans; Lysergic Acid Diethylamide; Me | 1973 |
L-dopa and the Shy-Drager syndrome.
Topics: Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fecal Incontinence; Flu | 1974 |